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Risk factors for B-cell non-Hodgkin lymphoma (B-NHL) have not been assessed among Pal-
estinian Arabs (PA) and Israeli Jews (IJ).
Methods
In a case-control study we investigated self-reported medical and lifestyle exposures,
reporting odds ratios (ORs) and 95% confidence intervals [CIs], by ethnicity, for overall B-
NHL and subtypes.
Results
We recruited 823 cases and 808 healthy controls. Among 307 PA/516 IJ B-NHL cases
(mean age at diagnosis = 51 [±17] versus 60 [±15] years, respectively) subtype distributions
differed, with diffuse large B-cell lymphoma (DLBCL) being prominent among PA (71%)
compared to IJ (41%); follicular lymphoma (FL), was observed in 14% versus 28%, and mar-
ginal zone lymphoma, in 2% versus 14%, respectively. Overall B-NHL in both populations
was associated with recreational sun exposure OR = 1.43 [CI:1.07–1.91], black hair-dye
use OR = 1.70 [CI:1.00–2.87], hospitalization for infection OR = 1.68 [CI:1.34–2.11], and
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first-degree relative with hematopoietic cancer, OR = 1.69 [CI:1.16–2.48]. An inverse asso-
ciation was noted with alcohol use, OR = 0.46 [CI:0.34–0.62]. Subtype-specific exposures
included smoking (FL, OR = 1.46 [CI:1.01–2.11]) and >monthly indoor pesticide use
(DLBCL, OR = 2.01 [CI:1.35–3.00]). Associations observed for overall B-NHL in PA only
included: gardening OR = 1.93 [CI:1.39–2.70]; history of herpes, mononucleosis, rubella,
blood transfusion (OR>2.5, P<0.01 for all); while for IJ risk factors included growing fruits
and vegetables, OR = 1.87 [CI:1.11–3.15]; and self-reported autoimmune diseases, OR =
1.99 [CI:1.34–2.95].
Conclusions
In these geographically proximate populations we found some unique risk factors for B-
NHL. Heterogeneity in the observed associations by ethnicity could reflect differences in life-
style, medical systems, and reporting patterns, while variations by histology infer specific eti-
ologic factors for lymphoma subtypes.
Introduction
Non-Hodgkin lymphomas (NHL) are histologically and molecularly heterogeneous malignan-
cies originating from B and T lymphocytes. They account for approximately 3% of the world-
wide cancer burden showing global variations in patterns of occurence[1]. NHL incidence
rates increased worldwide[2,3] from 1950–2000, tripling in those aged>65[4]. As of 2012,
Israel ranked first in the world in NHL incidence rates[5]; NHL represents the fifth most com-
mon malignancy in Israel[6], with annual age-adjusted incidence rates of 15.7 and 11.8/105 for
Jewish males and females respectively and 10.4 and 10.0/105 respectively for Israeli Arabs[6].
Israel ranks highest in the world in lymphoma incidence according to the World Health Orga-
nization, Globocan 2012 (IARC); Lebanon, in close geographic proximity, is ranked second
[5]. According to the Palestinian Cancer Registry as of 2014, NHL is the seventh among West
Bank Palestinian men and ninth among women[7]. The epidemiology of this important dis-
ease has remained relatively unstudied in both these populations.
Several risk factors and exposures have been consistently associated with lymphoma risks,
but these explain only a small fraction of NHL risk. Familial aggregation studies[8,9] as well as
genetic association studies point to an important hereditary component in the etiology of
NHL[10]. Alterations of the immune system by infections[11], autoimmune disorders[12] and
immunosuppression[1,13], whether acquired or congenital have been consistently related to
NHL susceptibility. The substantially increased incidence rates of NHL observed over the last
50 years strongly suggest the role of environmental factors[13]. These may include rural/agri-
cultural residence, occupational exposures to radiation[3] and certain chemicals (such as
insecticides and pesticides), cigarette smoking, and extended use of permanent dark hair dye
(all reviewed in Alexander et al, 2007). Several exposures have been associated with a decreased
risk of NHL including marijuana use[14],alcohol use[3,15,16] and history of blood transfusion
[17].
Several risk factors have been found to be subtype-specific[13]. In a large international
collaborative analysis including 17,471 NHL cases and 23,096 controls[17], pooled from
20 studies conducted in North America, Europe and Australia [International Lymphoma
Epidemiology Consortium (InterLymph)], associations varied among 11 NHL subtypes for
medical history factors (autoimmune diseases, hepatitis C virus, eczema, blood transfusion),
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alcohol consumption, cigarette smoking, and certain occupations. Risks were generally consis-
tent among subtypes for family history of NHL, recreational sun exposure, hay fever, allergies,
and socioeconomic status. Autoimmune diseases associated with B-cell activation were more
likely to elevate risk for B-cell non-Hodgkin lymphoma (B-NHL). Ethnicity was not explored
as a modifying factor in these associations.
In fact, to date, most epidemiological studies of NHL have been carried out in North Amer-
ican and European populations, with a few focusing on East Asian populations. Apart from
works from Oman[18] and Egypt[19], few case-control studies have focused on B-NHL in
Middle Eastern populations.
Israelis and Palestinians represent genetically and culturally diverse populations living in
geographic proximity. Despite sharing the same ecosystem, they differ in terms of lifestyle,
health behaviors and medical systems. This is the first large study examining medical history,
environmental and lifestyle risk factors for B-NHL and its subtypes in these populations.
Methods
Study design
We performed a case-control study which included questionnaires, pathology review, serology
and genotyping. This report includes data obtained from questionnaires and histopathology
review.
Trained interviewers approached potential cases after confirming potential eligibility of cases
(lymphoma type, diagnosis dates etc). Potential controls were approached as detailed below.
Study population
Inclusion criteria. Eligible cases were individuals aged18 years with pathologically con-
firmed B-NHL recruited from three sources: 1) outpatients and inpatients at Hadassah–
Hebrew University Medical Centre, a tertiary center on two campuses, recruited October
2010- March 2014 (N = 507 = 62%); 2) NHL patients from four hospitals in the center and
north of Israel (Chaim Sheba, Meir, Rambam and Hadassah Medical Centers) recruited to the
Israel Epilymph study in 2003 in (N = 86 = 10%); and 3) outpatients and inpatients attending
Nablus, Beit Jalla and Augusta Victoria Hospitals in the West Bank and East Jerusalem
(N = 170 = 21%), or recruited using the West Bank Cancer Registry files (N = 60 = 7%), 2009–
2013. Efforts were made to recruit cases as soon as possible after diagnosis. The median length
of time between diagnosis and interview was three months and 80% of cases were interviewed
within 1.5 years of diagnosis.
We obtained, where possible, original pathology reports for all enrolled cases from medical
records departments, private laboratories or computerized databases; where these were
unavailable we included cases with immunohistochemistry results explicitly recorded in the
treating physician’s report. Only cases showing positive immunohistochemistry staining with
CD20 or other B-cell markers were included. Cross-referencing of pathology reports was per-
formed with the Israel National Cancer Registry for cases recruited in Israel.
Healthy NHL-free controls were consenting individuals aged18 years frequency-matched
to cases by age and sex and recruited from various sources: They included consenting individ-
uals (not including blood relatives) accompanying patients to visits or appointments in 1)
hematology clinics and day care at Hadassah–Hebrew University Medical Center for the Israeli
Jewish (IJ) cases; and 2) National Hospital of Nablus, Augusta Victoria or Beit Jalla Hospitals
and 3) Ministry of Health centers distributed around the West Bank for the Palestinian Arab
(PA) cases. Due to occasional consanguineous marriage, spouses were not recruited in the PA
population, although they comprised 24% of IJ controls.
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Exclusion criteria were HIV positivity and inability to provide written informed consent
or complete the interview.
Questionnaire and study variables
Participants were interviewed utilizing a questionnaire adapted from the European Epilymph
study[20], and translated into Hebrew, Arabic and Russian. Questionnaire items focused on
family history, occupational and chemical exposures, hobbies, history of infection, and
immune conditions. Ethnicity for IJ was determined based on place of birth of four grandpar-
ents (Ashkenazi, North African, West Asian and Sephardic). For purposes of analysis Arab/
Muslim citizens of Israel (N = 5) were analyzed with the PAs. Although participants were not
questioned directly about their socio-economic status (SES), education level and frequency of
dental visits served as proxies for SES[21].
Statistical analysis
Differences in the distribution of socio-demographic variables and exposures were assessed
using two-sided Fisher’s exact and χ2 tests. Demographic variables found to differ in distribu-
tion between cases and controls entered as covariates in subsequent models. These included
marital status, education (yrs), ethnic origin for IJ and residential region for PA (North, South,
Center, other). Conditional logistic regression models were constructed to test associations
[reported as odds ratio (OR) and 95% confidence interval (CI)] between B-NHL status and
exposures, stratified by population (IJ, PA), frequency matched by sex and age categories
(4 year groupings). Individuals with missing data for the exposure variable of interest were
excluded from the models. Interactions were assessed between population group (the main
effect modifier of interest) and purported risk factor by adding an interaction term into the
conditional logistic model. If an interaction was found (interaction P value<0.05) pooling of
the populations was not performed. Models were constructed for specific B-NHL subtypes
including DLBCL, follicular lymphoma (FL), and MZL (the latter for IJ only, given limited
numbers among PA).
Sensitivity analyses were performed to examine the stability of our results for overall
B-NHL in the pooled population and subpopulations with the following exclusions:1) Epi-
lymph cases (as they had no concurrent controls); 2) spouse controls; 3) cases diagnosed >1.5
years after recruitment; 4) all three of the above; 5) spouse cases.
Sample size: Based on rates of exposure in controls of5%, two sided α = 0.05, a study with
800 cases and 800 controls provided at least 90% power to detect an OR of 2; a study with 516
cases and 414 controls provided at least 80% power to detect an OR of 2.2; and a study with
307 cases and 294 controls provided at least 80% power to detect an OR of 2.5.
In general, the alpha level was set at 0.05. We corrected the alpha level for multiple testing
using the Bonferroni correction (0.05/157 = 0.000318, based on the number of comparisons
performed (shown in Figs 1 and 2), when reporting novel associations or those that were not
consistent with previous findings reported by the InterLymph consortium on European/North
American populations[17].
Ethics
The study was approved by the ethics committees of Hadassah, Genetics Committee of the
Israel Ministry of Health, and the Institutional Review Board of the Palestinian Ministry of
Health. All participants provided written informed consent to participate in this study.
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Fig 1. Life style exposures- Adjusted OR for B-NHL and subtypes, overall and by population□. Lists the
overall odds ratio (OR) with 95% confidence interval (CI) for all risk factors affecting overall B-cell non-
Hodgkin lymphoma (B-NHL) and subtypes: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL)
and marginal zone lymphoma (MZL), stratified by population (Jews, Arabs), frequency matched by sex and
age categories (4 year groupings); adjusted for marital status, education (yrs), ethnic origin for Jews
(Ashkenazi, North African, West Asian and Sephardic) and residential region for Arabs (North, South, Center,
other). The columns list the exposure category and the OR. The colored grid indicates the OR associated with
the exposure for each subtype separately. Red (blue) represents the exposure increases (decreases) risk.
Xindicates an association with P<0.05, whereas XXindicates P<0.01. m indicates missing due to lack of data.
Int indicates interaction between exposure and sub-populations P<0.05. □based on schema designed by
Morton et al.
doi:10.1371/journal.pone.0171709.g001
Fig 2. Self-reported medical and family history- Adjusted OR for B-NHL and subtypes, overall and by
population□. Lists the overall odds ratio (OR) with 95% confidence interval (CI) for all risk factors affecting
overall B-cell non-Hodgkin lymphoma (B-NHL) and subtypes: diffuse large B-cell lymphoma (DLBCL), follicular
lymphoma (FL) and marginal zone lymphoma (MZL), stratified by population (Jews, Arabs), frequency matched
by sex and age categories (4 year groupings); adjusted for marital status, education (yrs), ethnic origin for Jews
(Ashkenazi, North African, West Asian and Sephardic) and residential region for Arabs (North, South, Center,
other). The columns list the exposure category and the OR. The colored grid indicates the OR associated with
the exposure for each subtype separately. Red (blue) represents the exposure increases (decreases) risk.
Xindicates an association with P<0.05, whereas XXindicates P<0.01. m indicates missing due to lack of data. Int
indicates interaction between exposure and sub-population P<0.05. No* category includes don’t know. □based
on schema designed by Morton et al. ♣Reported by Kleinstern et al.
doi:10.1371/journal.pone.0171709.g002
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Results
Response rates were95% for both IJ and PA cases; for controls, response rate was higher for
PA (95%) compared to IJ (75%). Among recruited PA cases, 77 (20%) were excluded for the
following reasons: verified age at diagnosis <18 yrs (N = 23); diagnostic review revealed Hodg-
kin or T-cell lymphoma (N = 26); inability to confirm B-NHL (N = 28). Among IJ cases, two
were excluded due to lack of immune staining (S1 Fig). Of the potentially eligible cases 10%
died before recruitment. Thus, our final study population consisted of 823 (307 PA/516 IJ)
cases, and 808 healthy controls (394 PA/414 IJ). Demographic characteristics are shown in
Table 1. PA participants had substantially larger family sizes than IJ; IJ were more likely to
have higher education (>12 years) than PA. Specifically, there are significant differences
between PA controls and IJ controls in terms of age, marital status, education level, number of
siblings, birth order and frequency of dental visits (P<0.01).
Table 1. Demographic characteristics for Israeli Jews and Palestinian Arabs by case-control status for overall B-cell non-Hodgkin lymphoma.






Characteristic Category N (%) N (%) N (%) N (%)
Total No. 516 (100) 414 (100) 307 (100) 394 (100)
Sex Male 260 (50.4) 185 (44.7) 0.08 154 (50.2) 168 (42.6) 0.05 0.55
Female 256 (49.6) 229 (55.3) 153 (49.8) 226 (57.4)
Age <34 33 (6.4) 45 (10.9) <0.01 64 (20.8) 54 (13.7) 0.05 <0.01
Years 35–54 145 (28.1) 111 (26.8) 108 (35.2) 174 (44.2)
55–64 135 (26.2) 111 (26.8) 64 (20.8) 85 (21.6)
65–74 111 (21.5) 111 (26.8) 47 (15.3) 52 (13.2)
75 92 (17.8) 36 (8.7) 24 (7.9) 29 (7.3)
Marital Single 29 (5.6) 19 (4.6) <0.01 41 (13.4) 34 (8.6) 0.02 <0.01
Status Married 374 (72.6) 382 (92.3) 232 (76.1) 333 (84.5)
Other 112 (21.8) 13 (3.1) 32 (10.5) 27 (6.9)
Ethnicity/ Ashkenazi 318 (61.6) 289 (70.0) <0.01 North 75 (24.7) 78 (19.8) <0.01 -
Region North African 83 (16.1) 46 (11.1) Center 120 (39.5) 130 (33.1)
West Asian 80 (15.5) 44 (10.7) South 97 (31.9) 176 (44.8)
Sephardic 35 (6.8) 34 (8.2) Other 12 (3.9) 9 (2.3)
Education 0–8 46 (9.0) 7 (1.7) <0.01 159 (53.0) 171 (44.3) 0.03 <0.01
Years 9–12 154 (30.1) 110 (26.6) 81 (27.0) 108 (28.0)
>12 312 (60.9) 297 (71.7) 60 (20.0) 107 (27.7)
Number 0–2 247 (49.2) 227 (54.8) 0.27 21 (6.9) 19 (4.9) 0.50 <0.01
of 3–5 157 (31.3) 116 (28.0) 81 (26.5) 101 (25.9)
Siblings 6 98 (19.5) 71 (17.2) 203 (66.6) 270 (69.2)
Birth order 1 178 (35.6) 151 (36.5) 0.23 71 (23.4) 69 (18.0) <0.01 <0.01
2–3 200 (40.0) 181 (43.7) 115 (37.8) 118 (30.9)
4 122 (24.4) 82 (19.8) 118 (38.8) 195 (51.1)
Frequency of Once/yr 236 (54.9) 254 (61.5) 0.15 45 (15.0) 61 (16.0) 0.20 <0.01
dental visits Toothache 183 (42.5 ( 150 (36.3) 227 (75.4) 298 (78.0)
Never 11 (2.6) 9 (2.2) 29 (9.6) 23 (6.0)
*Comparing cases and controls in this ethnic group.
Values were missing for < 1% of exposure variables.
doi:10.1371/journal.pone.0171709.t001
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Histologic distributions differed between populations (Fig 3), with the major subtype being
DLBCL in both: (217 (71%) PA vs 210 (41%) IJ). The mean age at diagnosis of B-NHL was
51 years [SD = 17], median 52 years, for PA compared to a mean and median of 60 years
[SD = 15] among IJ cases. Extensive demographic characteristics of the study population by
subtype are shown in Table A in S1 File. Lifestyle characteristics and environmental exposures
are summarized in Table B in S1 File. Table C in S1 File presents medical exposures and family
history.
Figs 1 and 2 depict case-control comparisons for the pooled dataset, by population, and by
subtype. As shown, certain factors were associated with B-NHL in the overall pooled popula-
tions (far left column). These included black hair dye use, recreational sun exposure9h/week
versus<4h/week, alcohol use, hospitalization for infection, self-reported hepatitis B or C, and
having a first or second degree relative with hematopoietic cancer (the latter was previously
reported by Kleinstern et al[22]).
In addition, subtype-specific associations were seen in the pooled populations for cigarette
smoking (FL) OR = 1.46 (CI:1.01–2.11); black hair dye use (DLBCL) OR = 1.88 (CI:1.03–3.43);
recreational sun exposure (DLBCL, P trend<0.0001),9h/week OR = 1.47 (CI:1.03–1.80); and 4-
8h/week versus<4h/week OR = 1.25 (CI:0.87–1.80); pesticide use indoors (DLBCL: P trend<
0.0001)>once/month OR = 2.01 (CI:1.35–3.00),<once/month OR = 1.07 (CI:0.75–1.52); alcohol
use (DLBCL, FL) OR = 0.40 (CI:0.27–0.59), OR = 0.47 (CI:0.30–0.72) respectively; hospitalization
for infection (DLBCL) OR = 1.48 (CI:1.12–1.96); having a first degree relative with hematopoietic
cancer (DLBCL) OR = 1.83 (CI:1.17–2.87) (previously reported by Kleinstern et al[22]).
Regarding population-specific findings, factors that were positively associated with DLBCL
in PA only included gardening as a hobby OR = 2.00 (CI:1.38–2.92); history of labial herpes
OR = 4.82 (CI:2.90–8.02); mononucleosis OR = 8.42 (CI:2.59–27.3); rubella OR = 3.99
(CI:1.65–9.64); and blood transfusion OR = 2.57 (CI:1.56–4.22).
On the other hand, associations observed exclusively in IJ included fruit and vegetable gar-
dening (DLBCL) OR = 2.35 (CI:1.05–5.26); and a history of auto-immune diseases for DLBCL,
OR = 1.91 (CI:1.14–3.21); FL, OR = 2.34 (CI:1.31–4.15); and MZL, OR = 2.60 (CI:1.22–5.52),
respectively.
We found significant heterogeneity between PA and IJ in terms of associations with
some exposures. Gardening was associated with overall B-NHL and DLBCL only in PA (p =
0.00004, and p = 0.0001, respectively); fruit and vegetable gardening was associated with
DLBCL only in IJ; pesticide use indoors>once/month had a positive association with overall
B-NHL only in PA. Previous hospitalization for infection was positively associated with FL
Fig 3. B-cell non-Hodgkin lymphoma (B-NHL) subtype distribution by population.
doi:10.1371/journal.pone.0171709.g003
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only in IJ. History of blood transfusion showed a positive association with overall B-NHL,
DLBCL and FL only in PA (p = 0.0005, p = 0.002. and p = 0.11, respectively. Strong associa-
tions (OR>2) with self-reported herpes, rubella and mononucleosis were observed only
among PA. A full description of the observed associations appears in Table D in S1 File.
Sensitivity analyses of the overall B-NHL associations excluding Epilymph cases, spouse
controls/cases and prevalent cases did not substantially change the effect sizes or conclusions
from the all-inclusive analysis, although statistical precision varied (Table E in S1 File).
Discussion
In this multicenter case-control study of B-NHL in previously unstudied populations we
found that distributions histologic subtypes differed, with DLBCL by far the most common
subtype in PA (71%). The histologic distribution for IJ reflects that reported in Western popu-
lations[17], for PA the distribution was even more markedly skewed toward DLBCL than that
found in Saudi Arabia[23] (51% DLBCL, 7% FL and 5% MZL) or Jordan[24] (62% DLBCL
and 14% indolent lymphoma). Jordan’s population is similar genetically and culturally to the
PAs. In contrast, a study in Lebanon[25], a country with high NHL incidence[5] reported 44%
DLBCL and 20% FL resembling the proportion in our IJ cases.
B-NHL was diagnosed on average nine years younger in PA versus IJ. This most likely due
to the younger age structure of the Palestinian population, although it is possible that there is
under-diagnosis of cases, especially indolent NHL in older individuals. The median age at
diagnosis for IJ is consistent with InterLymph[17]. Here too, findings from Lebanon[25]
resembled those in our IJ population, with a mean age at diagnosis of 58 years for DLBCL
cases.
Regarding lifestyle factors, both populations exhibited similar associations with NHL. Ciga-
rette smoking was associated with FL only, consistent with Interlymph results[17] as well a
cohort study in the United States[26]. Alcohol consumption was protective for all subtypes,
although this exposure, as expected, was rarely reported among the mainly Muslim PA. The
InterLymph[17] study also reported a negative association between alcohol and DLBCL and
MZL. A systematic review including 21 case-control and eight cohort studies reported that
alcohol consumption was negatively associated with NHL independent of beverage type[15].
Inhibition of mammalian target of rapamycin (mTOR) signaling in lymphocytes by chronic
ethanol exposure[27], has been proposed as a possible mechanism for the favorable role of
alcohol on NHL risk.
Recreational sun exposure showed a positive association with DLBCL for the pooled popu-
lation (but a negative association with FL in PA). This unexpected result may be a chance find-
ing as did not meet the Bonferroni corrected threshold of P<0.00318. It is in contrast to the
InterLymph findings[17] which showed a negative association for all B-NHL subtypes. How-
ever, a recent US study, while confirming a generally inverse association between sun exposure
and lymphoma, found heterogeneity both by subtype and by race/ethnicity[28]. The latitude
of Israel/West Bank differs from that in previous studies of NHL and sun exposure, and the
general high level of sun exposure in our populations, combined with skin color differences,
may explain discrepancies with previously observed relations[29].
Gardening as a hobby was positively associated with overall B-NHL and DLBCL only for
PA, and retained its statistical significance even after adjusting for multiple comparisons. This
"hobby" was more prevalent in the PA (47.7%) versus IJ population (36.7%), reflecting differ-
ences in residential arrangements of the two populations. Most West Bank homes have gar-
dens, used mainly for fruit and olive trees as well as vegetables, and not for flowers or lawns,
while the majority of IJ are urbanized and live in apartment buildings. Paradoxically, fruit and
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vegetable gardening per se, was positively associated with overall B-NHL and DLBCL for IJ
only. In both populations these "hobbies" may reflect exposure to pesticides, although other
exposures, such as to UV radiation via sun exposure are also possible.
The validity of some self-reported medical history items may be questioned. Despite pre-
testing the questionnaire in the PA population, lack of knowledge of medical history and
stigma about certain diseases may have limited the accuracy of some responses. This under-
scores the importance of using biomarkers as unbiased indicators of disease antecedents[22].
The IJ population demonstrated a significant positive association between autoimmune dis-
eases with overall B-NHL and all subtypes consistent with the InterLymph[30] results for
DLBCL and MZL whereas responses were blank for 38% of PA participants. History of blood
transfusion showed a highly significant positive association for PA only, and the finding per-
sisted after Bonferroni correction. This may be due to more recent hepatitis viral contamina-
tion of the blood supply[31,32] or to possible misclassification of exposure during or after
diagnosis of B-NHL instead of prior to disease onset. In contrast, InterLymph[17] reported
blood transfusion to be protective for B-NHL. Antecedent self-reported viral exposures such
as herpes, mononucleosis and rubella were associated with B-NHL in PA only, and there were
substantial differences between the populations in reported exposure rates in controls. In addi-
tion, hospitalization for infection was positively associated with overall B-NHL and DLBCL in
the pooled result, echoing the results in the Jerusalem Perinatal Cohort Study which reported
an association between this exposure in infancy and increased risk of aggressive B-NHL[33].
This finding supports the notion that underlying immunodeficiency may be an important risk
factor for B-NHL.
As expected, in the pooled results, a positive family history of hematopoietic cancer was
positively associated with both overall B-NHL and DLBCL, consistent with InterLymph[8]
results, among others, supporting an hereditary component in B-NHL etiology in our region
as well.
The strengths of this case-control study include the large sample size in previously unstud-
ied multi-ethnic populations. The high participation rate among cases (95%) enhances the
representativeness of this sample. A majority of our pooled findings corroborate results in
international studies, attesting to the study’s external validity.
Specific challenges in this study include suboptimal recruitment of IJ male controls, as
well as potential bias related to the method of control selection. That being said, our controls
resembled the general population in terms of ethnic distribution and lifestyle exposures such
as smoking[34]. Recruitment strategies based on accompanying friends and visitors has been
previously used and validated in cancer epidemiology[35]. Some of the IJ controls were
spouses of participating B-NHL cases, and this may have resulted in over-matching for envi-
ronmental exposures, biasing the study towards the null. However, our analysis strategy, using
strata of age and sex, meant that spouse controls were never directly compared to the corre-
sponding case. Furthermore, excluding these controls did not alter the results (Table E in
S1 File).
In addition, the possibility of survivorship bias may pertain to the 20% cases recruited
>18 months after diagnosis. However, only 10% of the potentially eligible study population
died before recruitment reducing the potential for this bias, and sensitivity analysis exclud-
ing these cases yielded stable results in the overall B-NHL associations. Finally, the possibil-
ity of recall bias and misclassification of exposures ascertained after disease onset (eg blood
transfusion), raise the probability of reverse causality. We did not adjust for multiple com-
parisons; hence some chance findings are possible, although many of the associations had a
high prior probability, confirming previously reported findings from the Interlymph pool-
ing projects.
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In conclusion, in the Israeli and West Bank Palestinian populations a variety of exposures
were related to overall B-NHL. These include infectious, lifestyle and family history exposures.
Some were subtype-specific, inferring specific etiologic factors for particular NHL subtypes (eg
smoking and FL), which require further investigation as to their mechanisms. Other associa-
tions point to substantial etiologic heterogeneity between the populations. Effect modification
by ethnicity raises the possibility of gene-environment interactions, but also may reflect differ-
ences in diet, cultural habits, socioeconomic, environmental and housing conditions, medical
services, exposure to infections in early life or other factors. Cancer epidemiology will be
enriched through the broadening of analytic research to include under-studied populations
from a variety of ethnicities and geographic regions. This study reflects a unique joint scientific
effort involving Israeli and Palestinian investigators, and demonstrates the importance of
cooperative research even in politically uncertain climates.
Supporting information
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